Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
[Contribution to the diagnosis and differential diagnosis of cavities localized in the upper part of the lung].

Tuberkuloza

LA GRASTA M.
PMID: 14413131
Tuberkuloza. 1960 Jan-Mar;12:104-13.

No abstract available.

Cite
LA GRASTA M. [Contribution to the diagnosis and differential diagnosis of cavities localized in the upper part of the lung]. Tuberkuloza. 1960;12:104-13
LA GRASTA, M. (1960). [Contribution to the diagnosis and differential diagnosis of cavities localized in the upper part of the lung]. Tuberkuloza, 12104-13.
LA GRASTA, M. "[Contribution to the diagnosis and differential diagnosis of cavities localized in the upper part of the lung]." Tuberkuloza vol. 12 (1960): 104-13.
LA GRASTA M. [Contribution to the diagnosis and differential diagnosis of cavities localized in the upper part of the lung]. Tuberkuloza. 1960 Jan-Mar;12:104-13. Undetermined. PMID: 14413131.
Copy Download .nbib Format: NLM
Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study).

BMJ open

Ornaghi S, Colciago E, Vaglio Tessitore I, Abbamondi A, Antolini L, Locatelli A, Inversetti A, Pintucci A, Cetin I, Bracco B, Fabbri E, Sala V, Meroni M, Volpe G, Benedetti S, Bulfoni C, Marconi A, Lagrasta F, Paolini CL, Mazza E, Candiani M, Valsecchi L, Smid M, Pasi F, Pozzoni M, Castoldi M, Vignali M, Dal Molin G, Guarano A, Pellegrino A, Callegari C, Betti M, Lazzarin S, Prefumo F, Zanardini C, Parolin V, Catalano A, Barbolini E, Antonazzo P, Pignatti L, Tintoni M, Spelzini F, Martinelli A, Facchinetti F, Chiossi G, Vergani P.
PMID: 34873004
BMJ Open. 2021 Dec 06;11(12):e052510. doi: 10.1136/bmjopen-2021-052510.

INTRODUCTION: The term placenta praevia defines a placenta that lies over the internal os, whereas the term low-lying placenta identifies a placenta that is partially implanted in the lower uterine segment with the inferior placental edge located at 1-20...

Cite
Ornaghi S, Colciago E, Vaglio Tessitore I, et al. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study). BMJ Open. 2021;11(12):e052510doi: 10.1136/bmjopen-2021-052510.
Ornaghi, S., Colciago, E., Vaglio Tessitore, I., Abbamondi, A., Antolini, L., Locatelli, A., Inversetti, A., Pintucci, A., Cetin, I., Bracco, B., Fabbri, E., Sala, V., Meroni, M., Volpe, G., Benedetti, S., Bulfoni, C., Marconi, A., Lagrasta, F., Paolini, C. L., Mazza, E., Candiani, M., Valsecchi, L., Smid, M., Pasi, F., Pozzoni, M., Castoldi, M., Vignali, M., Dal Molin, G., Guarano, A., Pellegrino, A., Callegari, C., Betti, M., Lazzarin, S., Prefumo, F., Zanardini, C., Parolin, V., Catalano, A., Barbolini, E., Antonazzo, P., Pignatti, L., Tintoni, M., Spelzini, F., Martinelli, A., Facchinetti, F., Chiossi, G., & Vergani, P. (2021). Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study). BMJ open, 11(12), e052510. https://doi.org/10.1136/bmjopen-2021-052510
Ornaghi, Sara, et al. "Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study)." BMJ open vol. 11,12 (2021): e052510. doi: https://doi.org/10.1136/bmjopen-2021-052510
Ornaghi S, Colciago E, Vaglio Tessitore I, Abbamondi A, Antolini L, Locatelli A, Inversetti A, Pintucci A, Cetin I, Bracco B, Fabbri E, Sala V, Meroni M, Volpe G, Benedetti S, Bulfoni C, Marconi A, Lagrasta F, Paolini CL, Mazza E, Candiani M, Valsecchi L, Smid M, Pasi F, Pozzoni M, Castoldi M, Vignali M, Dal Molin G, Guarano A, Pellegrino A, Callegari C, Betti M, Lazzarin S, Prefumo F, Zanardini C, Parolin V, Catalano A, Barbolini E, Antonazzo P, Pignatti L, Tintoni M, Spelzini F, Martinelli A, Facchinetti F, Chiossi G, Vergani P. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case-control study in Italy (the MODEL-PLACENTA study). BMJ Open. 2021 Dec 06;11(12):e052510. doi: 10.1136/bmjopen-2021-052510. PMID: 34873004.
Copy Download .nbib Format: NLM
Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering.

Biomimetics (Basel, Switzerland)

Rosellini E, Madeddu D, Barbani N, Frati C, Graiani G, Falco A, Lagrasta C, Quaini F, Cascone MG.
PMID: 33322426
Biomimetics (Basel). 2020 Dec 11;5(4). doi: 10.3390/biomimetics5040067.

In recent years, there has been an increasing interest toward the covalent binding of bioactive peptides from extracellular matrix proteins on scaffolds as a promising functionalization strategy in the development of biomimetic matrices for tissue engineering. A totally new...

Cite
Rosellini E, Madeddu D, Barbani N, et al. Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering. Biomimetics (Basel). 2020;5(4)doi: 10.3390/biomimetics5040067.
Rosellini, E., Madeddu, D., Barbani, N., Frati, C., Graiani, G., Falco, A., Lagrasta, C., Quaini, F., & Cascone, M. G. (2020). Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering. Biomimetics (Basel, Switzerland), 5(4), . https://doi.org/10.3390/biomimetics5040067
Rosellini, Elisabetta, et al. "Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering." Biomimetics (Basel, Switzerland) vol. 5,4 (2020). doi: https://doi.org/10.3390/biomimetics5040067
Rosellini E, Madeddu D, Barbani N, Frati C, Graiani G, Falco A, Lagrasta C, Quaini F, Cascone MG. Development of Biomimetic Alginate/Gelatin/Elastin Sponges with Recognition Properties toward Bioactive Peptides for Cardiac Tissue Engineering. Biomimetics (Basel). 2020 Dec 11;5(4). doi: 10.3390/biomimetics5040067. PMID: 33322426; PMCID: PMC7768388.
Copy Download .nbib Format: NLM
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium.

Journal of biomaterials applications

Rosellini E, Barbani N, Frati C, Madeddu D, Massai D, Morbiducci U, Lazzeri L, Falco A, Graiani G, Lagrasta C, Audenino A, Cascone MG, Quaini F.
PMID: 32772783
J Biomater Appl. 2021 Feb;35(7):762-775. doi: 10.1177/0885328220948501. Epub 2020 Aug 09.

The use of injectable scaffolds to repair the infarcted heart is receiving great interest. Thermosensitive polymers,

Cite
Rosellini E, Barbani N, Frati C, et al. IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium. J Biomater Appl. 2020;35(7):762-775doi: 10.1177/0885328220948501.
Rosellini, E., Barbani, N., Frati, C., Madeddu, D., Massai, D., Morbiducci, U., Lazzeri, L., Falco, A., Graiani, G., Lagrasta, C., Audenino, A., Cascone, M. G., & Quaini, F. (2021). IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium. Journal of biomaterials applications, 35(7), 762-775. https://doi.org/10.1177/0885328220948501
Rosellini, Elisabetta, et al. "IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium." Journal of biomaterials applications vol. 35,7 (2021): 762-775. doi: https://doi.org/10.1177/0885328220948501
Rosellini E, Barbani N, Frati C, Madeddu D, Massai D, Morbiducci U, Lazzeri L, Falco A, Graiani G, Lagrasta C, Audenino A, Cascone MG, Quaini F. IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium. J Biomater Appl. 2021 Feb;35(7):762-775. doi: 10.1177/0885328220948501. Epub 2020 Aug 09. PMID: 32772783.
Copy Download .nbib Format: NLM
The Failing Heart.

Advances in clinical pathology : the official journal of Adriatic Society of Pathology

Olivetti G, Cigola E, Maestri R, Lagrasta C, Quaini F.
PMID: 10352477
Adv Clin Path. 1997 Apr;1(2):137-148.

Heart failure is a highly lethal condition which carries a shorter life expectancy than most common malignancies. Despite the large number of efforts dedicated to understand why the heart fails, only limited possibilities are available to improve survival. This...

Cite
Olivetti G, Cigola E, Maestri R, et al. The Failing Heart. Adv Clin Path. 1997;1(2):137-148
Olivetti, G., Cigola, E., Maestri, R., Lagrasta, C., & Quaini, F. (1997). The Failing Heart. Advances in clinical pathology : the official journal of Adriatic Society of Pathology, 1(2), 137-148.
Olivetti, et al. "The Failing Heart." Advances in clinical pathology : the official journal of Adriatic Society of Pathology vol. 1,2 (1997): 137-148.
Olivetti G, Cigola E, Maestri R, Lagrasta C, Quaini F. The Failing Heart. Adv Clin Path. 1997 Apr;1(2):137-148. PMID: 10352477.
Copy Download .nbib Format: NLM
[Pulmonary tuberculosis].

Tuberkuloza

La Grasta M.
PMID: 16296049
Tuberkuloza. 1966 Sep-Oct;18(5):446-50.

No abstract available.

Cite
La Grasta M. Tuberkulom pluća. [Pulmonary tuberculosis]. Tuberkuloza. 1966;18(5):446-50
La Grasta, M. (1966). Tuberkulom pluća. [Pulmonary tuberculosis]. Tuberkuloza, 18(5), 446-50.
La Grasta, M. "Tuberkulom pluća." [Pulmonary tuberculosis]. Tuberkuloza vol. 18,5 (1966): 446-50.
La Grasta M. Tuberkulom pluća. [Pulmonary tuberculosis]. Tuberkuloza. 1966 Sep-Oct;18(5):446-50. Croatian. PMID: 16296049.
Copy Download .nbib Format: NLM
Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib.

Anti-cancer drugs

Minari R, Leonetti A, Gnetti L, Zielli T, Ventura L, Bottarelli L, Lagrasta C, La Monica S, Petronini PG, Alfieri R, Tiseo M.
PMID: 33675607
Anticancer Drugs. 2021 Aug 01;32(7):758-762. doi: 10.1097/CAD.0000000000001064.

Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) used both as the first-line treatment of EGFR-mutated non-small cell lung cancer patients and in second-line after T790M-positive disease progression to first- or second-generation TKIs. Unfortunately, patients unavoidably...

Cite
Minari R, Leonetti A, Gnetti L, et al. Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anticancer Drugs. 2021;32(7):758-762doi: 10.1097/CAD.0000000000001064.
Minari, R., Leonetti, A., Gnetti, L., Zielli, T., Ventura, L., Bottarelli, L., Lagrasta, C., La Monica, S., Petronini, P. G., Alfieri, R., & Tiseo, M. (2021). Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anti-cancer drugs, 32(7), 758-762. https://doi.org/10.1097/CAD.0000000000001064
Minari, Roberta, et al. "Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib." Anti-cancer drugs vol. 32,7 (2021): 758-762. doi: https://doi.org/10.1097/CAD.0000000000001064
Minari R, Leonetti A, Gnetti L, Zielli T, Ventura L, Bottarelli L, Lagrasta C, La Monica S, Petronini PG, Alfieri R, Tiseo M. Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib. Anticancer Drugs. 2021 Aug 01;32(7):758-762. doi: 10.1097/CAD.0000000000001064. PMID: 33675607.
Copy Download .nbib Format: NLM
Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.

EXCLI journal

Finelli C, Crispino P, Gioia S, La Sala N, D'amico L, La Grotta M, Miro O, Colarusso D.
PMID: 27932940
EXCLI J. 2016 Sep 19;15:570. doi: 10.17179/excli2016-570. eCollection 2016.

[This retracts the article DOI: 10.17179/excli2015-642.].

Cite
Finelli C, Crispino P, Gioia S, et al. Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J. 2016;15:570doi: 10.17179/excli2016-570.
Finelli, C., Crispino, P., Gioia, S., La Sala, N., D'amico, L., La Grotta, M., Miro, O., & Colarusso, D. (2016). Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI journal, 15570. https://doi.org/10.17179/excli2016-570
Finelli, C, et al. "Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss." EXCLI journal vol. 15 (2016): 570. doi: https://doi.org/10.17179/excli2016-570
Finelli C, Crispino P, Gioia S, La Sala N, D'amico L, La Grotta M, Miro O, Colarusso D. Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J. 2016 Sep 19;15:570. doi: 10.17179/excli2016-570. eCollection 2016. PMID: 27932940; PMCID: PMC5138495.
Copy Download .nbib Format: NLM
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies.

Radiology and oncology

Tuzi A, Lombardi D, Crivellari D, Militello L, Perin T, La Grassa M, Massarut S, Veronesi A.
PMID: 23450278
Radiol Oncol. 2013 Mar;47(1):57-62. doi: 10.2478/raon-2013-0012. Epub 2013 Feb 01.

BACKGROUND: We report on the activity of the combination of epirubicin and docetaxel given in neoadjuvant setting for 4 and 8 cycles respectively in 2 successive series of patients with large operable or locally advanced, hormone receptor positive, HER-2...

Cite
Tuzi A, Lombardi D, Crivellari D, et al. Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies. Radiol Oncol. 2013;47(1):57-62doi: 10.2478/raon-2013-0012.
Tuzi, A., Lombardi, D., Crivellari, D., Militello, L., Perin, T., La Grassa, M., Massarut, S., & Veronesi, A. (2013). Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies. Radiology and oncology, 47(1), 57-62. https://doi.org/10.2478/raon-2013-0012
Tuzi, Alessandro, et al. "Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies." Radiology and oncology vol. 47,1 (2013): 57-62. doi: https://doi.org/10.2478/raon-2013-0012
Tuzi A, Lombardi D, Crivellari D, Militello L, Perin T, La Grassa M, Massarut S, Veronesi A. Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies. Radiol Oncol. 2013 Mar;47(1):57-62. doi: 10.2478/raon-2013-0012. Epub 2013 Feb 01. PMID: 23450278; PMCID: PMC3573835.
Copy Download .nbib Format: NLM
Simulation training improves team dynamics and performance in a low-resource cardiac intensive care unit.

Annals of pediatric cardiology

Emani SS, Allan CK, Forster T, Fisk AC, Lagrasta C, Zheleva B, Weinstock P, Thiagarajan RR.
PMID: 29922009
Ann Pediatr Cardiol. 2018 May-Aug;11(2):130-136. doi: 10.4103/apc.APC_117_17.

INTRODUCTION: Although simulation training has been utilized quite extensively in highincome medical environments, its feasibility and effect on team performance in lowresource pediatric Cardiac Intensive Care Unit (CICU) environments has not been demonstrated. We hypothesized that lowfidelity simulationbased crisis...

Cite
Emani SS, Allan CK, Forster T, et al. Simulation training improves team dynamics and performance in a low-resource cardiac intensive care unit. Ann Pediatr Cardiol. 2018;11(2):130-136doi: 10.4103/apc.APC_117_17.
Emani, S. S., Allan, C. K., Forster, T., Fisk, A. C., Lagrasta, C., Zheleva, B., Weinstock, P., & Thiagarajan, R. R. (2018). Simulation training improves team dynamics and performance in a low-resource cardiac intensive care unit. Annals of pediatric cardiology, 11(2), 130-136. https://doi.org/10.4103/apc.APC_117_17
Emani, Sivaram Subaya, et al. "Simulation training improves team dynamics and performance in a low-resource cardiac intensive care unit." Annals of pediatric cardiology vol. 11,2 (2018): 130-136. doi: https://doi.org/10.4103/apc.APC_117_17
Emani SS, Allan CK, Forster T, Fisk AC, Lagrasta C, Zheleva B, Weinstock P, Thiagarajan RR. Simulation training improves team dynamics and performance in a low-resource cardiac intensive care unit. Ann Pediatr Cardiol. 2018 May-Aug;11(2):130-136. doi: 10.4103/apc.APC_117_17. PMID: 29922009; PMCID: PMC5963226.
Copy Download .nbib Format: NLM
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer.

Data in brief

Mazzaschi G, Milanese G, Pagano P, Madeddu D, Gnetti L, Trentini F, Falco A, Frati C, Lorusso B, Lagrasta C, Minari R, Ampollini L, Silva M, Sverzellati N, Quaini F, Roti G, Tiseo M.
PMID: 32548224
Data Brief. 2020 Jun 02;31:105781. doi: 10.1016/j.dib.2020.105781. eCollection 2020 Aug.

The immune regulation of cancer growth and regression has been underscored by the recent success of immunotherapy. The possibility that immune microenvironmental factors may impact on clinical outcome and treatment response still requires intense investigations. Hereby, supporting data of...

Cite
Mazzaschi G, Milanese G, Pagano P, et al. Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. Data Brief. 2020;31:105781doi: 10.1016/j.dib.2020.105781.
Mazzaschi, G., Milanese, G., Pagano, P., Madeddu, D., Gnetti, L., Trentini, F., Falco, A., Frati, C., Lorusso, B., Lagrasta, C., Minari, R., Ampollini, L., Silva, M., Sverzellati, N., Quaini, F., Roti, G., & Tiseo, M. (2020). Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. Data in brief, 31105781. https://doi.org/10.1016/j.dib.2020.105781
Mazzaschi, Giulia, et al. "Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer." Data in brief vol. 31 (2020): 105781. doi: https://doi.org/10.1016/j.dib.2020.105781
Mazzaschi G, Milanese G, Pagano P, Madeddu D, Gnetti L, Trentini F, Falco A, Frati C, Lorusso B, Lagrasta C, Minari R, Ampollini L, Silva M, Sverzellati N, Quaini F, Roti G, Tiseo M. Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. Data Brief. 2020 Jun 02;31:105781. doi: 10.1016/j.dib.2020.105781. eCollection 2020 Aug. PMID: 32548224; PMCID: PMC7286984.
Copy Download .nbib Format: NLM
The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.

EXCLI journal

Finelli C, Crispino P, Gioia S, La Sala N, D'amico L, La Grotta M, Miro O, Colarusso D.
PMID: 27103896
EXCLI J. 2016 Feb 23;15:166-76. doi: 10.17179/excli2015-642. eCollection 2016.

Depressed levels of atheroprotective large HDL particles are common in obesity and cardiovascular disease (CVD). Increases in large HDL particles are favourably associated with reduced CVD event risk and coronary plaque burden. The objective of the study is to...

Cite
Finelli C, Crispino P, Gioia S, et al. The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J. 2016;15:166-76doi: 10.17179/excli2015-642.
Finelli, C., Crispino, P., Gioia, S., La Sala, N., D'amico, L., La Grotta, M., Miro, O., & Colarusso, D. (2016). The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI journal, 15166-76. https://doi.org/10.17179/excli2015-642
Finelli, C, et al. "The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss." EXCLI journal vol. 15 (2016): 166-76. doi: https://doi.org/10.17179/excli2015-642
Finelli C, Crispino P, Gioia S, La Sala N, D'amico L, La Grotta M, Miro O, Colarusso D. The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J. 2016 Feb 23;15:166-76. doi: 10.17179/excli2015-642. eCollection 2016. PMID: 27103896; PMCID: PMC4834750.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries